GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2,194 Cr | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹991 Cr |
| Mar2023 | ₹4,348 Cr |
| Mar2022 | ₹3,670 Cr |
| Mar2021 | ₹4,687 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 121.50 | |
| Mar2024 | ₹991 Cr | -77.22 | |
| Mar2023 | ₹4,348 Cr | 18.46 | |
| Mar2022 | ₹3,670 Cr | -21.70 | |
| Mar2021 | ₹4,687 Cr | - | |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,720.8 Cr | 1% | 4.6% | 30.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1% |
4.6% |
30.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses